Safety and Efficacy Study of Endothelial Progenitor Cell Capture Stent With 1 Months Dual Antiplatelet Therapy (INNOVATION)

This study has been terminated.
(Previous other study including EPC capture stent raised the issue of safety (significant high incidence of instent restenosis))
Yuhan Corporation
Information provided by (Responsible Party):
Seung-Hwan Lee, Yonsei University Identifier:
First received: July 11, 2011
Last updated: December 3, 2013
Last verified: December 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2013
  Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)